nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—AKR1C3—stomach cancer	0.352	0.751	CbGaD
Naproxen—AKR1C3—Doxorubicin—stomach cancer	0.0961	0.297	CbGbCtD
Naproxen—PTGS2—stomach cancer	0.0616	0.132	CbGaD
Naproxen—UGT2B7—Epirubicin—stomach cancer	0.0565	0.175	CbGbCtD
Naproxen—ALB—stomach cancer	0.0549	0.117	CbGaD
Naproxen—UGT1A1—Irinotecan—stomach cancer	0.0475	0.147	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—stomach cancer	0.0184	0.057	CbGbCtD
Naproxen—ALB—Irinotecan—stomach cancer	0.018	0.0557	CbGbCtD
Naproxen—ALB—Fluorouracil—stomach cancer	0.0173	0.0534	CbGbCtD
Naproxen—CYP2C9—Capecitabine—stomach cancer	0.0157	0.0486	CbGbCtD
Naproxen—CYP2C8—Fluorouracil—stomach cancer	0.0133	0.0413	CbGbCtD
Naproxen—SLC22A6—Methotrexate—stomach cancer	0.0112	0.0346	CbGbCtD
Naproxen—CYP1A2—Fluorouracil—stomach cancer	0.0103	0.032	CbGbCtD
Naproxen—ALB—Methotrexate—stomach cancer	0.00953	0.0295	CbGbCtD
Naproxen—CYP2C9—Fluorouracil—stomach cancer	0.00931	0.0288	CbGbCtD
Naproxen—ALB—gall bladder—stomach cancer	0.00109	0.0543	CbGeAlD
Naproxen—UGT1A1—hematopoietic system—stomach cancer	0.000918	0.0457	CbGeAlD
Naproxen—AKR1C3—smooth muscle tissue—stomach cancer	0.000877	0.0436	CbGeAlD
Naproxen—AKR1C3—pancreas—stomach cancer	0.000811	0.0403	CbGeAlD
Naproxen—UGT2B7—digestive system—stomach cancer	0.000751	0.0374	CbGeAlD
Naproxen—Ibuprofen—THBD—stomach cancer	0.000721	0.198	CrCbGaD
Naproxen—PTGS1—blood vessel—stomach cancer	0.000662	0.0329	CbGeAlD
Naproxen—UGT1A1—digestive system—stomach cancer	0.000639	0.0318	CbGeAlD
Naproxen—AKR1C3—bone marrow—stomach cancer	0.000638	0.0318	CbGeAlD
Naproxen—PTGS2—blood vessel—stomach cancer	0.000632	0.0315	CbGeAlD
Naproxen—SLCO1A2—hematopoietic system—stomach cancer	0.000622	0.0309	CbGeAlD
Naproxen—UGT2B7—endocrine gland—stomach cancer	0.000621	0.0309	CbGeAlD
Naproxen—PTGS2—gall bladder—stomach cancer	0.000595	0.0296	CbGeAlD
Naproxen—UGT2B7—liver—stomach cancer	0.00056	0.0278	CbGeAlD
Naproxen—UGT1A1—endocrine gland—stomach cancer	0.000528	0.0262	CbGeAlD
Naproxen—AKR1C3—liver—stomach cancer	0.000516	0.0257	CbGeAlD
Naproxen—Indomethacin—AKR1C3—stomach cancer	0.000481	0.132	CrCbGaD
Naproxen—UGT1A1—liver—stomach cancer	0.000476	0.0237	CbGeAlD
Naproxen—CYP2C8—hematopoietic system—stomach cancer	0.000434	0.0216	CbGeAlD
Naproxen—SLCO1A2—digestive system—stomach cancer	0.000432	0.0215	CbGeAlD
Naproxen—CYP1A2—hematopoietic system—stomach cancer	0.000407	0.0202	CbGeAlD
Naproxen—AKR1C3—lymph node—stomach cancer	0.000396	0.0197	CbGeAlD
Naproxen—CYP2C9—hematopoietic system—stomach cancer	0.000386	0.0192	CbGeAlD
Naproxen—SLCO1A2—endocrine gland—stomach cancer	0.000357	0.0178	CbGeAlD
Naproxen—PTGS1—hematopoietic system—stomach cancer	0.000352	0.0175	CbGeAlD
Naproxen—PTGS2—hematopoietic system—stomach cancer	0.000337	0.0168	CbGeAlD
Naproxen—SLCO1A2—liver—stomach cancer	0.000322	0.016	CbGeAlD
Naproxen—PTGS1—epithelium—stomach cancer	0.000322	0.016	CbGeAlD
Naproxen—ALB—liver—stomach cancer	0.00032	0.0159	CbGeAlD
Naproxen—PTGS1—smooth muscle tissue—stomach cancer	0.00031	0.0154	CbGeAlD
Naproxen—PTGS2—epithelium—stomach cancer	0.000308	0.0153	CbGeAlD
Naproxen—PTGS2—smooth muscle tissue—stomach cancer	0.000297	0.0148	CbGeAlD
Naproxen—Indomethacin—CXCL8—stomach cancer	0.000289	0.0792	CrCbGaD
Naproxen—CYP1A2—digestive system—stomach cancer	0.000283	0.0141	CbGeAlD
Naproxen—PTGS2—pancreas—stomach cancer	0.000274	0.0136	CbGeAlD
Naproxen—CYP2C9—digestive system—stomach cancer	0.000268	0.0133	CbGeAlD
Naproxen—CYP2C8—endocrine gland—stomach cancer	0.00025	0.0124	CbGeAlD
Naproxen—ALB—lymph node—stomach cancer	0.000246	0.0122	CbGeAlD
Naproxen—PTGS1—digestive system—stomach cancer	0.000245	0.0122	CbGeAlD
Naproxen—PTGS2—lymphoid tissue—stomach cancer	0.000237	0.0118	CbGeAlD
Naproxen—PTGS2—digestive system—stomach cancer	0.000234	0.0116	CbGeAlD
Naproxen—CYP1A2—endocrine gland—stomach cancer	0.000234	0.0116	CbGeAlD
Naproxen—Ketoprofen—CXCL8—stomach cancer	0.000231	0.0634	CrCbGaD
Naproxen—Ibuprofen—CXCL8—stomach cancer	0.000228	0.0624	CrCbGaD
Naproxen—CYP2C8—liver—stomach cancer	0.000225	0.0112	CbGeAlD
Naproxen—Nabumetone—PTGS2—stomach cancer	0.000225	0.0617	CrCbGaD
Naproxen—CYP2C9—endocrine gland—stomach cancer	0.000222	0.011	CbGeAlD
Naproxen—PTGS2—bone marrow—stomach cancer	0.000216	0.0107	CbGeAlD
Naproxen—Carprofen—PTGS2—stomach cancer	0.000215	0.0588	CrCbGaD
Naproxen—CYP1A2—liver—stomach cancer	0.000211	0.0105	CbGeAlD
Naproxen—PTGS1—endocrine gland—stomach cancer	0.000202	0.0101	CbGeAlD
Naproxen—CYP2C9—liver—stomach cancer	0.0002	0.00995	CbGeAlD
Naproxen—Indomethacin—PPARG—stomach cancer	0.0002	0.0547	CrCbGaD
Naproxen—PTGS2—endocrine gland—stomach cancer	0.000194	0.00963	CbGeAlD
Naproxen—PTGS2—liver—stomach cancer	0.000174	0.00868	CbGeAlD
Naproxen—Ibuprofen—PPARG—stomach cancer	0.000157	0.0431	CrCbGaD
Naproxen—PTGS1—lymph node—stomach cancer	0.00014	0.00696	CbGeAlD
Naproxen—PTGS2—lymph node—stomach cancer	0.000134	0.00665	CbGeAlD
Naproxen—Suprofen—PTGS2—stomach cancer	0.000133	0.0363	CrCbGaD
Naproxen—Fenoprofen—PTGS2—stomach cancer	0.000114	0.0313	CrCbGaD
Naproxen—Fenoprofen—ALB—stomach cancer	0.000102	0.0279	CrCbGaD
Naproxen—Indomethacin—PTGS2—stomach cancer	8.43e-05	0.0231	CrCbGaD
Naproxen—Indomethacin—ALB—stomach cancer	7.51e-05	0.0206	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—stomach cancer	7.45e-05	0.0204	CrCbGaD
Naproxen—Ketoprofen—PTGS2—stomach cancer	6.74e-05	0.0185	CrCbGaD
Naproxen—Flurbiprofen—ALB—stomach cancer	6.64e-05	0.0182	CrCbGaD
Naproxen—Ibuprofen—PTGS2—stomach cancer	6.64e-05	0.0182	CrCbGaD
Naproxen—Ketoprofen—ALB—stomach cancer	6.01e-05	0.0165	CrCbGaD
Naproxen—Ibuprofen—ALB—stomach cancer	5.91e-05	0.0162	CrCbGaD
Naproxen—Vomiting—Fluorouracil—stomach cancer	4.68e-05	0.000341	CcSEcCtD
Naproxen—Rhinitis—Doxorubicin—stomach cancer	4.68e-05	0.000341	CcSEcCtD
Naproxen—Dyspepsia—Docetaxel—stomach cancer	4.67e-05	0.000341	CcSEcCtD
Naproxen—Haemorrhage—Doxorubicin—stomach cancer	4.66e-05	0.00034	CcSEcCtD
Naproxen—Hepatitis—Doxorubicin—stomach cancer	4.66e-05	0.00034	CcSEcCtD
Naproxen—Insomnia—Capecitabine—stomach cancer	4.65e-05	0.000339	CcSEcCtD
Naproxen—Rash—Fluorouracil—stomach cancer	4.64e-05	0.000338	CcSEcCtD
Naproxen—Dermatitis—Fluorouracil—stomach cancer	4.63e-05	0.000338	CcSEcCtD
Naproxen—Pharyngitis—Doxorubicin—stomach cancer	4.63e-05	0.000338	CcSEcCtD
Naproxen—Paraesthesia—Capecitabine—stomach cancer	4.62e-05	0.000337	CcSEcCtD
Naproxen—Decreased appetite—Docetaxel—stomach cancer	4.62e-05	0.000337	CcSEcCtD
Naproxen—Headache—Fluorouracil—stomach cancer	4.61e-05	0.000336	CcSEcCtD
Naproxen—Urinary tract disorder—Doxorubicin—stomach cancer	4.61e-05	0.000336	CcSEcCtD
Naproxen—Oedema peripheral—Doxorubicin—stomach cancer	4.6e-05	0.000335	CcSEcCtD
Naproxen—Gastrointestinal disorder—Docetaxel—stomach cancer	4.58e-05	0.000334	CcSEcCtD
Naproxen—Connective tissue disorder—Doxorubicin—stomach cancer	4.58e-05	0.000334	CcSEcCtD
Naproxen—Dyspnoea—Capecitabine—stomach cancer	4.58e-05	0.000334	CcSEcCtD
Naproxen—Fatigue—Docetaxel—stomach cancer	4.58e-05	0.000334	CcSEcCtD
Naproxen—Angiopathy—Epirubicin—stomach cancer	4.57e-05	0.000334	CcSEcCtD
Naproxen—Urethral disorder—Doxorubicin—stomach cancer	4.57e-05	0.000333	CcSEcCtD
Naproxen—Nausea—Irinotecan—stomach cancer	4.56e-05	0.000333	CcSEcCtD
Naproxen—Immune system disorder—Epirubicin—stomach cancer	4.55e-05	0.000332	CcSEcCtD
Naproxen—Mediastinal disorder—Epirubicin—stomach cancer	4.54e-05	0.000331	CcSEcCtD
Naproxen—Pain—Docetaxel—stomach cancer	4.54e-05	0.000331	CcSEcCtD
Naproxen—Constipation—Docetaxel—stomach cancer	4.54e-05	0.000331	CcSEcCtD
Naproxen—Dyspepsia—Capecitabine—stomach cancer	4.53e-05	0.00033	CcSEcCtD
Naproxen—Chills—Epirubicin—stomach cancer	4.52e-05	0.00033	CcSEcCtD
Naproxen—Arrhythmia—Epirubicin—stomach cancer	4.5e-05	0.000328	CcSEcCtD
Naproxen—Visual impairment—Doxorubicin—stomach cancer	4.5e-05	0.000328	CcSEcCtD
Naproxen—Decreased appetite—Capecitabine—stomach cancer	4.47e-05	0.000326	CcSEcCtD
Naproxen—Alopecia—Epirubicin—stomach cancer	4.46e-05	0.000325	CcSEcCtD
Naproxen—Gastrointestinal disorder—Capecitabine—stomach cancer	4.44e-05	0.000324	CcSEcCtD
Naproxen—Fatigue—Capecitabine—stomach cancer	4.43e-05	0.000323	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—stomach cancer	4.42e-05	0.000322	CcSEcCtD
Naproxen—Mental disorder—Epirubicin—stomach cancer	4.42e-05	0.000322	CcSEcCtD
Naproxen—Erythema multiforme—Doxorubicin—stomach cancer	4.41e-05	0.000322	CcSEcCtD
Naproxen—Pain—Capecitabine—stomach cancer	4.4e-05	0.000321	CcSEcCtD
Naproxen—Constipation—Capecitabine—stomach cancer	4.4e-05	0.000321	CcSEcCtD
Naproxen—Malnutrition—Epirubicin—stomach cancer	4.39e-05	0.00032	CcSEcCtD
Naproxen—Erythema—Epirubicin—stomach cancer	4.39e-05	0.00032	CcSEcCtD
Naproxen—Feeling abnormal—Docetaxel—stomach cancer	4.38e-05	0.000319	CcSEcCtD
Naproxen—Nausea—Fluorouracil—stomach cancer	4.37e-05	0.000319	CcSEcCtD
Naproxen—Eye disorder—Doxorubicin—stomach cancer	4.36e-05	0.000318	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—stomach cancer	4.35e-05	0.000317	CcSEcCtD
Naproxen—Tinnitus—Doxorubicin—stomach cancer	4.35e-05	0.000317	CcSEcCtD
Naproxen—Gastrointestinal pain—Docetaxel—stomach cancer	4.34e-05	0.000317	CcSEcCtD
Naproxen—Anaemia—Methotrexate—stomach cancer	4.33e-05	0.000316	CcSEcCtD
Naproxen—Cardiac disorder—Doxorubicin—stomach cancer	4.33e-05	0.000316	CcSEcCtD
Naproxen—Flatulence—Epirubicin—stomach cancer	4.32e-05	0.000315	CcSEcCtD
Naproxen—Tension—Epirubicin—stomach cancer	4.31e-05	0.000314	CcSEcCtD
Naproxen—Nervousness—Epirubicin—stomach cancer	4.26e-05	0.000311	CcSEcCtD
Naproxen—Feeling abnormal—Capecitabine—stomach cancer	4.24e-05	0.000309	CcSEcCtD
Naproxen—Angiopathy—Doxorubicin—stomach cancer	4.23e-05	0.000309	CcSEcCtD
Naproxen—Malaise—Methotrexate—stomach cancer	4.23e-05	0.000308	CcSEcCtD
Naproxen—Muscle spasms—Epirubicin—stomach cancer	4.22e-05	0.000308	CcSEcCtD
Naproxen—Immune system disorder—Doxorubicin—stomach cancer	4.21e-05	0.000307	CcSEcCtD
Naproxen—Vertigo—Methotrexate—stomach cancer	4.21e-05	0.000307	CcSEcCtD
Naproxen—Gastrointestinal pain—Capecitabine—stomach cancer	4.2e-05	0.000307	CcSEcCtD
Naproxen—Mediastinal disorder—Doxorubicin—stomach cancer	4.2e-05	0.000307	CcSEcCtD
Naproxen—Body temperature increased—Docetaxel—stomach cancer	4.2e-05	0.000306	CcSEcCtD
Naproxen—Abdominal pain—Docetaxel—stomach cancer	4.2e-05	0.000306	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—stomach cancer	4.2e-05	0.000306	CcSEcCtD
Naproxen—Chills—Doxorubicin—stomach cancer	4.19e-05	0.000305	CcSEcCtD
Naproxen—Arrhythmia—Doxorubicin—stomach cancer	4.17e-05	0.000304	CcSEcCtD
Naproxen—Vision blurred—Epirubicin—stomach cancer	4.14e-05	0.000302	CcSEcCtD
Naproxen—Alopecia—Doxorubicin—stomach cancer	4.12e-05	0.000301	CcSEcCtD
Naproxen—Cough—Methotrexate—stomach cancer	4.09e-05	0.000298	CcSEcCtD
Naproxen—Mental disorder—Doxorubicin—stomach cancer	4.09e-05	0.000298	CcSEcCtD
Naproxen—Urticaria—Capecitabine—stomach cancer	4.08e-05	0.000298	CcSEcCtD
Naproxen—Ill-defined disorder—Epirubicin—stomach cancer	4.07e-05	0.000297	CcSEcCtD
Naproxen—Abdominal pain—Capecitabine—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Body temperature increased—Capecitabine—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Convulsion—Methotrexate—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Malnutrition—Doxorubicin—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Erythema—Doxorubicin—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Anaemia—Epirubicin—stomach cancer	4.06e-05	0.000296	CcSEcCtD
Naproxen—Flatulence—Doxorubicin—stomach cancer	4e-05	0.000292	CcSEcCtD
Naproxen—Chest pain—Methotrexate—stomach cancer	3.99e-05	0.000291	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—stomach cancer	3.99e-05	0.000291	CcSEcCtD
Naproxen—Myalgia—Methotrexate—stomach cancer	3.99e-05	0.000291	CcSEcCtD
Naproxen—Tension—Doxorubicin—stomach cancer	3.98e-05	0.000291	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	3.97e-05	0.000289	CcSEcCtD
Naproxen—Malaise—Epirubicin—stomach cancer	3.96e-05	0.000289	CcSEcCtD
Naproxen—Discomfort—Methotrexate—stomach cancer	3.94e-05	0.000288	CcSEcCtD
Naproxen—Nervousness—Doxorubicin—stomach cancer	3.94e-05	0.000288	CcSEcCtD
Naproxen—Vertigo—Epirubicin—stomach cancer	3.94e-05	0.000288	CcSEcCtD
Naproxen—Syncope—Epirubicin—stomach cancer	3.94e-05	0.000287	CcSEcCtD
Naproxen—Leukopenia—Epirubicin—stomach cancer	3.93e-05	0.000286	CcSEcCtD
Naproxen—Hypersensitivity—Docetaxel—stomach cancer	3.91e-05	0.000285	CcSEcCtD
Naproxen—Muscle spasms—Doxorubicin—stomach cancer	3.9e-05	0.000285	CcSEcCtD
Naproxen—Palpitations—Epirubicin—stomach cancer	3.88e-05	0.000283	CcSEcCtD
Naproxen—Confusional state—Methotrexate—stomach cancer	3.86e-05	0.000281	CcSEcCtD
Naproxen—Loss of consciousness—Epirubicin—stomach cancer	3.86e-05	0.000281	CcSEcCtD
Naproxen—Cough—Epirubicin—stomach cancer	3.83e-05	0.000279	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—stomach cancer	3.83e-05	0.000279	CcSEcCtD
Naproxen—Vision blurred—Doxorubicin—stomach cancer	3.83e-05	0.000279	CcSEcCtD
Naproxen—Asthenia—Docetaxel—stomach cancer	3.81e-05	0.000278	CcSEcCtD
Naproxen—Convulsion—Epirubicin—stomach cancer	3.8e-05	0.000277	CcSEcCtD
Naproxen—Infection—Methotrexate—stomach cancer	3.8e-05	0.000277	CcSEcCtD
Naproxen—Hypertension—Epirubicin—stomach cancer	3.79e-05	0.000276	CcSEcCtD
Naproxen—Hypersensitivity—Capecitabine—stomach cancer	3.79e-05	0.000276	CcSEcCtD
Naproxen—Ill-defined disorder—Doxorubicin—stomach cancer	3.77e-05	0.000275	CcSEcCtD
Naproxen—Pruritus—Docetaxel—stomach cancer	3.76e-05	0.000274	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—stomach cancer	3.75e-05	0.000274	CcSEcCtD
Naproxen—Anaemia—Doxorubicin—stomach cancer	3.75e-05	0.000274	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—stomach cancer	3.75e-05	0.000273	CcSEcCtD
Naproxen—Chest pain—Epirubicin—stomach cancer	3.74e-05	0.000272	CcSEcCtD
Naproxen—Arthralgia—Epirubicin—stomach cancer	3.74e-05	0.000272	CcSEcCtD
Naproxen—Myalgia—Epirubicin—stomach cancer	3.74e-05	0.000272	CcSEcCtD
Naproxen—Anxiety—Epirubicin—stomach cancer	3.72e-05	0.000272	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—stomach cancer	3.72e-05	0.000271	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	3.71e-05	0.000271	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—stomach cancer	3.7e-05	0.00027	CcSEcCtD
Naproxen—Discomfort—Epirubicin—stomach cancer	3.69e-05	0.000269	CcSEcCtD
Naproxen—Asthenia—Capecitabine—stomach cancer	3.69e-05	0.000269	CcSEcCtD
Naproxen—Malaise—Doxorubicin—stomach cancer	3.66e-05	0.000267	CcSEcCtD
Naproxen—Dry mouth—Epirubicin—stomach cancer	3.65e-05	0.000266	CcSEcCtD
Naproxen—Vertigo—Doxorubicin—stomach cancer	3.65e-05	0.000266	CcSEcCtD
Naproxen—Anorexia—Methotrexate—stomach cancer	3.65e-05	0.000266	CcSEcCtD
Naproxen—Syncope—Doxorubicin—stomach cancer	3.64e-05	0.000266	CcSEcCtD
Naproxen—Pruritus—Capecitabine—stomach cancer	3.64e-05	0.000265	CcSEcCtD
Naproxen—Leukopenia—Doxorubicin—stomach cancer	3.63e-05	0.000265	CcSEcCtD
Naproxen—Diarrhoea—Docetaxel—stomach cancer	3.63e-05	0.000265	CcSEcCtD
Naproxen—Confusional state—Epirubicin—stomach cancer	3.61e-05	0.000263	CcSEcCtD
Naproxen—Palpitations—Doxorubicin—stomach cancer	3.59e-05	0.000262	CcSEcCtD
Naproxen—Oedema—Epirubicin—stomach cancer	3.58e-05	0.000261	CcSEcCtD
Naproxen—Anaphylactic shock—Epirubicin—stomach cancer	3.58e-05	0.000261	CcSEcCtD
Naproxen—Hypotension—Methotrexate—stomach cancer	3.58e-05	0.000261	CcSEcCtD
Naproxen—Loss of consciousness—Doxorubicin—stomach cancer	3.57e-05	0.00026	CcSEcCtD
Naproxen—Infection—Epirubicin—stomach cancer	3.56e-05	0.000259	CcSEcCtD
Naproxen—Cough—Doxorubicin—stomach cancer	3.54e-05	0.000258	CcSEcCtD
Naproxen—Shock—Epirubicin—stomach cancer	3.52e-05	0.000257	CcSEcCtD
Naproxen—Convulsion—Doxorubicin—stomach cancer	3.52e-05	0.000257	CcSEcCtD
Naproxen—Diarrhoea—Capecitabine—stomach cancer	3.52e-05	0.000257	CcSEcCtD
Naproxen—Nervous system disorder—Epirubicin—stomach cancer	3.51e-05	0.000256	CcSEcCtD
Naproxen—Dizziness—Docetaxel—stomach cancer	3.51e-05	0.000256	CcSEcCtD
Naproxen—Thrombocytopenia—Epirubicin—stomach cancer	3.51e-05	0.000256	CcSEcCtD
Naproxen—Hypertension—Doxorubicin—stomach cancer	3.51e-05	0.000256	CcSEcCtD
Naproxen—Tachycardia—Epirubicin—stomach cancer	3.5e-05	0.000255	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.49e-05	0.000254	CcSEcCtD
Naproxen—Skin disorder—Epirubicin—stomach cancer	3.48e-05	0.000254	CcSEcCtD
Naproxen—Hyperhidrosis—Epirubicin—stomach cancer	3.46e-05	0.000252	CcSEcCtD
Naproxen—Insomnia—Methotrexate—stomach cancer	3.46e-05	0.000252	CcSEcCtD
Naproxen—Arthralgia—Doxorubicin—stomach cancer	3.46e-05	0.000252	CcSEcCtD
Naproxen—Chest pain—Doxorubicin—stomach cancer	3.46e-05	0.000252	CcSEcCtD
Naproxen—Myalgia—Doxorubicin—stomach cancer	3.46e-05	0.000252	CcSEcCtD
Naproxen—Anxiety—Doxorubicin—stomach cancer	3.45e-05	0.000251	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—stomach cancer	3.44e-05	0.000251	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	3.43e-05	0.00025	CcSEcCtD
Naproxen—Discomfort—Doxorubicin—stomach cancer	3.42e-05	0.000249	CcSEcCtD
Naproxen—Anorexia—Epirubicin—stomach cancer	3.41e-05	0.000249	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—stomach cancer	3.41e-05	0.000249	CcSEcCtD
Naproxen—Somnolence—Methotrexate—stomach cancer	3.4e-05	0.000248	CcSEcCtD
Naproxen—Dizziness—Capecitabine—stomach cancer	3.4e-05	0.000248	CcSEcCtD
Naproxen—Dry mouth—Doxorubicin—stomach cancer	3.38e-05	0.000247	CcSEcCtD
Naproxen—Vomiting—Docetaxel—stomach cancer	3.38e-05	0.000246	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—stomach cancer	3.37e-05	0.000246	CcSEcCtD
Naproxen—Rash—Docetaxel—stomach cancer	3.35e-05	0.000244	CcSEcCtD
Naproxen—Hypotension—Epirubicin—stomach cancer	3.35e-05	0.000244	CcSEcCtD
Naproxen—Dermatitis—Docetaxel—stomach cancer	3.35e-05	0.000244	CcSEcCtD
Naproxen—Confusional state—Doxorubicin—stomach cancer	3.34e-05	0.000244	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—stomach cancer	3.33e-05	0.000243	CcSEcCtD
Naproxen—Headache—Docetaxel—stomach cancer	3.33e-05	0.000243	CcSEcCtD
Naproxen—Oedema—Doxorubicin—stomach cancer	3.31e-05	0.000242	CcSEcCtD
Naproxen—Anaphylactic shock—Doxorubicin—stomach cancer	3.31e-05	0.000242	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—stomach cancer	3.3e-05	0.000241	CcSEcCtD
Naproxen—Fatigue—Methotrexate—stomach cancer	3.3e-05	0.000241	CcSEcCtD
Naproxen—Infection—Doxorubicin—stomach cancer	3.29e-05	0.00024	CcSEcCtD
Naproxen—Pain—Methotrexate—stomach cancer	3.27e-05	0.000239	CcSEcCtD
Naproxen—Vomiting—Capecitabine—stomach cancer	3.27e-05	0.000238	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.26e-05	0.000238	CcSEcCtD
Naproxen—Shock—Doxorubicin—stomach cancer	3.26e-05	0.000238	CcSEcCtD
Naproxen—Nervous system disorder—Doxorubicin—stomach cancer	3.25e-05	0.000237	CcSEcCtD
Naproxen—Thrombocytopenia—Doxorubicin—stomach cancer	3.24e-05	0.000237	CcSEcCtD
Naproxen—Rash—Capecitabine—stomach cancer	3.24e-05	0.000236	CcSEcCtD
Naproxen—Insomnia—Epirubicin—stomach cancer	3.24e-05	0.000236	CcSEcCtD
Naproxen—Dermatitis—Capecitabine—stomach cancer	3.24e-05	0.000236	CcSEcCtD
Naproxen—Tachycardia—Doxorubicin—stomach cancer	3.23e-05	0.000236	CcSEcCtD
Naproxen—Headache—Capecitabine—stomach cancer	3.22e-05	0.000235	CcSEcCtD
Naproxen—Skin disorder—Doxorubicin—stomach cancer	3.22e-05	0.000235	CcSEcCtD
Naproxen—Paraesthesia—Epirubicin—stomach cancer	3.22e-05	0.000235	CcSEcCtD
Naproxen—Hyperhidrosis—Doxorubicin—stomach cancer	3.2e-05	0.000234	CcSEcCtD
Naproxen—Dyspnoea—Epirubicin—stomach cancer	3.19e-05	0.000233	CcSEcCtD
Naproxen—Somnolence—Epirubicin—stomach cancer	3.18e-05	0.000232	CcSEcCtD
Naproxen—Anorexia—Doxorubicin—stomach cancer	3.16e-05	0.00023	CcSEcCtD
Naproxen—Nausea—Docetaxel—stomach cancer	3.15e-05	0.00023	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—stomach cancer	3.15e-05	0.00023	CcSEcCtD
Naproxen—Dyspepsia—Epirubicin—stomach cancer	3.15e-05	0.00023	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—stomach cancer	3.13e-05	0.000228	CcSEcCtD
Naproxen—Decreased appetite—Epirubicin—stomach cancer	3.11e-05	0.000227	CcSEcCtD
Naproxen—Hypotension—Doxorubicin—stomach cancer	3.1e-05	0.000226	CcSEcCtD
Naproxen—Gastrointestinal disorder—Epirubicin—stomach cancer	3.09e-05	0.000225	CcSEcCtD
Naproxen—Fatigue—Epirubicin—stomach cancer	3.09e-05	0.000225	CcSEcCtD
Naproxen—Constipation—Epirubicin—stomach cancer	3.06e-05	0.000223	CcSEcCtD
Naproxen—Pain—Epirubicin—stomach cancer	3.06e-05	0.000223	CcSEcCtD
Naproxen—Nausea—Capecitabine—stomach cancer	3.05e-05	0.000223	CcSEcCtD
Naproxen—Urticaria—Methotrexate—stomach cancer	3.04e-05	0.000222	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—stomach cancer	3.03e-05	0.000221	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—stomach cancer	3.03e-05	0.000221	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.02e-05	0.00022	CcSEcCtD
Naproxen—Insomnia—Doxorubicin—stomach cancer	3e-05	0.000219	CcSEcCtD
Naproxen—Paraesthesia—Doxorubicin—stomach cancer	2.98e-05	0.000217	CcSEcCtD
Naproxen—Dyspnoea—Doxorubicin—stomach cancer	2.95e-05	0.000215	CcSEcCtD
Naproxen—Feeling abnormal—Epirubicin—stomach cancer	2.95e-05	0.000215	CcSEcCtD
Naproxen—Somnolence—Doxorubicin—stomach cancer	2.95e-05	0.000215	CcSEcCtD
Naproxen—Gastrointestinal pain—Epirubicin—stomach cancer	2.93e-05	0.000214	CcSEcCtD
Naproxen—Dyspepsia—Doxorubicin—stomach cancer	2.92e-05	0.000213	CcSEcCtD
Naproxen—Decreased appetite—Doxorubicin—stomach cancer	2.88e-05	0.00021	CcSEcCtD
Naproxen—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.86e-05	0.000209	CcSEcCtD
Naproxen—Fatigue—Doxorubicin—stomach cancer	2.86e-05	0.000208	CcSEcCtD
Naproxen—Urticaria—Epirubicin—stomach cancer	2.85e-05	0.000207	CcSEcCtD
Naproxen—Pain—Doxorubicin—stomach cancer	2.83e-05	0.000207	CcSEcCtD
Naproxen—Constipation—Doxorubicin—stomach cancer	2.83e-05	0.000207	CcSEcCtD
Naproxen—Abdominal pain—Epirubicin—stomach cancer	2.83e-05	0.000206	CcSEcCtD
Naproxen—Body temperature increased—Epirubicin—stomach cancer	2.83e-05	0.000206	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—stomach cancer	2.82e-05	0.000206	CcSEcCtD
Naproxen—Asthenia—Methotrexate—stomach cancer	2.75e-05	0.0002	CcSEcCtD
Naproxen—Feeling abnormal—Doxorubicin—stomach cancer	2.73e-05	0.000199	CcSEcCtD
Naproxen—Gastrointestinal pain—Doxorubicin—stomach cancer	2.71e-05	0.000198	CcSEcCtD
Naproxen—Pruritus—Methotrexate—stomach cancer	2.71e-05	0.000197	CcSEcCtD
Naproxen—Hypersensitivity—Epirubicin—stomach cancer	2.64e-05	0.000192	CcSEcCtD
Naproxen—Urticaria—Doxorubicin—stomach cancer	2.63e-05	0.000192	CcSEcCtD
Naproxen—Abdominal pain—Doxorubicin—stomach cancer	2.62e-05	0.000191	CcSEcCtD
Naproxen—Body temperature increased—Doxorubicin—stomach cancer	2.62e-05	0.000191	CcSEcCtD
Naproxen—Diarrhoea—Methotrexate—stomach cancer	2.62e-05	0.000191	CcSEcCtD
Naproxen—Asthenia—Epirubicin—stomach cancer	2.57e-05	0.000187	CcSEcCtD
Naproxen—Pruritus—Epirubicin—stomach cancer	2.53e-05	0.000185	CcSEcCtD
Naproxen—Dizziness—Methotrexate—stomach cancer	2.53e-05	0.000185	CcSEcCtD
Naproxen—Diarrhoea—Epirubicin—stomach cancer	2.45e-05	0.000179	CcSEcCtD
Naproxen—Hypersensitivity—Doxorubicin—stomach cancer	2.44e-05	0.000178	CcSEcCtD
Naproxen—Vomiting—Methotrexate—stomach cancer	2.43e-05	0.000177	CcSEcCtD
Naproxen—Rash—Methotrexate—stomach cancer	2.41e-05	0.000176	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—stomach cancer	2.41e-05	0.000176	CcSEcCtD
Naproxen—Headache—Methotrexate—stomach cancer	2.4e-05	0.000175	CcSEcCtD
Naproxen—Asthenia—Doxorubicin—stomach cancer	2.38e-05	0.000173	CcSEcCtD
Naproxen—Dizziness—Epirubicin—stomach cancer	2.37e-05	0.000173	CcSEcCtD
Naproxen—Pruritus—Doxorubicin—stomach cancer	2.34e-05	0.000171	CcSEcCtD
Naproxen—Vomiting—Epirubicin—stomach cancer	2.28e-05	0.000166	CcSEcCtD
Naproxen—Nausea—Methotrexate—stomach cancer	2.27e-05	0.000166	CcSEcCtD
Naproxen—Diarrhoea—Doxorubicin—stomach cancer	2.27e-05	0.000165	CcSEcCtD
Naproxen—Rash—Epirubicin—stomach cancer	2.26e-05	0.000165	CcSEcCtD
Naproxen—Dermatitis—Epirubicin—stomach cancer	2.26e-05	0.000165	CcSEcCtD
Naproxen—Headache—Epirubicin—stomach cancer	2.24e-05	0.000164	CcSEcCtD
Naproxen—Dizziness—Doxorubicin—stomach cancer	2.19e-05	0.00016	CcSEcCtD
Naproxen—Nausea—Epirubicin—stomach cancer	2.13e-05	0.000155	CcSEcCtD
Naproxen—Vomiting—Doxorubicin—stomach cancer	2.11e-05	0.000154	CcSEcCtD
Naproxen—Rash—Doxorubicin—stomach cancer	2.09e-05	0.000152	CcSEcCtD
Naproxen—Dermatitis—Doxorubicin—stomach cancer	2.09e-05	0.000152	CcSEcCtD
Naproxen—Headache—Doxorubicin—stomach cancer	2.08e-05	0.000151	CcSEcCtD
Naproxen—Nausea—Doxorubicin—stomach cancer	1.97e-05	0.000144	CcSEcCtD
Naproxen—UGT2B7—Metabolism—APOA1—stomach cancer	7.49e-06	0.000156	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTM1—stomach cancer	7.48e-06	0.000156	CbGpPWpGaD
Naproxen—AKR1C3—Disease—STAT3—stomach cancer	7.36e-06	0.000154	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLCE1—stomach cancer	7.32e-06	0.000153	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALDH7A1—stomach cancer	7.32e-06	0.000153	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKR1C3—stomach cancer	7.31e-06	0.000153	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RHOA—stomach cancer	7.3e-06	0.000152	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NOS3—stomach cancer	7.22e-06	0.000151	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.21e-06	0.000151	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.19e-06	0.00015	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TYMP—stomach cancer	7.18e-06	0.00015	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—FADS1—stomach cancer	7.18e-06	0.00015	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.17e-06	0.00015	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.15e-06	0.000149	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ENO1—stomach cancer	7.12e-06	0.000149	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALOX5—stomach cancer	7.11e-06	0.000149	CbGpPWpGaD
Naproxen—PTGS2—Disease—HBEGF—stomach cancer	7.09e-06	0.000148	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—stomach cancer	7.08e-06	0.000148	CbGpPWpGaD
Naproxen—ALB—Metabolism—ALOX5—stomach cancer	7.07e-06	0.000148	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ERCC2—stomach cancer	7.03e-06	0.000147	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MAPK3—stomach cancer	7.03e-06	0.000147	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—UMPS—stomach cancer	7.02e-06	0.000147	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7e-06	0.000146	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DPYD—stomach cancer	6.99e-06	0.000146	CbGpPWpGaD
Naproxen—ALB—Metabolism—DPYD—stomach cancer	6.95e-06	0.000145	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MYC—stomach cancer	6.84e-06	0.000143	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	6.8e-06	0.000142	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPP2R1A—stomach cancer	6.77e-06	0.000141	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ERBB2—stomach cancer	6.75e-06	0.000141	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SREBF2—stomach cancer	6.72e-06	0.00014	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MAPK1—stomach cancer	6.69e-06	0.00014	CbGpPWpGaD
Naproxen—AKR1C3—Disease—EGFR—stomach cancer	6.69e-06	0.00014	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—RORA—stomach cancer	6.64e-06	0.000139	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTP1—stomach cancer	6.64e-06	0.000139	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—stomach cancer	6.61e-06	0.000138	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARG—stomach cancer	6.6e-06	0.000138	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HMOX1—stomach cancer	6.54e-06	0.000137	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CAV1—stomach cancer	6.53e-06	0.000137	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PDHA1—stomach cancer	6.52e-06	0.000136	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ECHS1—stomach cancer	6.52e-06	0.000136	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOA1—stomach cancer	6.52e-06	0.000136	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	6.5e-06	0.000136	CbGpPWpGaD
Naproxen—PTGS2—Disease—PPP2R1A—stomach cancer	6.41e-06	0.000134	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL8—stomach cancer	6.41e-06	0.000134	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.34e-06	0.000132	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD44—stomach cancer	6.32e-06	0.000132	CbGpPWpGaD
Naproxen—AKR1C3—Disease—KRAS—stomach cancer	6.32e-06	0.000132	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.3e-06	0.000132	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1B—stomach cancer	6.26e-06	0.000131	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.24e-06	0.00013	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SERPINE1—stomach cancer	6.24e-06	0.00013	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALDOB—stomach cancer	6.22e-06	0.00013	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTT1—stomach cancer	6.18e-06	0.000129	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TYMS—stomach cancer	6.17e-06	0.000129	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTT1—stomach cancer	6.15e-06	0.000129	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—FADS1—stomach cancer	6.13e-06	0.000128	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TYMP—stomach cancer	6.13e-06	0.000128	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP2A6—stomach cancer	6.11e-06	0.000128	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CAV1—stomach cancer	6.1e-06	0.000127	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTM1—stomach cancer	6.1e-06	0.000127	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOA1—stomach cancer	6.08e-06	0.000127	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP2A6—stomach cancer	6.08e-06	0.000127	CbGpPWpGaD
Naproxen—ALB—Hemostasis—RHOA—stomach cancer	6.02e-06	0.000126	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCND1—stomach cancer	5.97e-06	0.000125	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—JUN—stomach cancer	5.95e-06	0.000124	CbGpPWpGaD
Naproxen—PTGS2—Disease—SMAD4—stomach cancer	5.95e-06	0.000124	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS3—stomach cancer	5.95e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKR1C3—stomach cancer	5.95e-06	0.000124	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—stomach cancer	5.93e-06	0.000124	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKR1C3—stomach cancer	5.91e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.87e-06	0.000123	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.85e-06	0.000122	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PIK3CA—stomach cancer	5.8e-06	0.000121	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ENO1—stomach cancer	5.79e-06	0.000121	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—stomach cancer	5.79e-06	0.000121	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALOX5—stomach cancer	5.79e-06	0.000121	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1A—stomach cancer	5.77e-06	0.000121	CbGpPWpGaD
Naproxen—ALB—Metabolism—ENO1—stomach cancer	5.76e-06	0.00012	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARG—stomach cancer	5.74e-06	0.00012	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SREBF2—stomach cancer	5.74e-06	0.00012	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ERCC2—stomach cancer	5.73e-06	0.00012	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.7e-06	0.000119	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DPYD—stomach cancer	5.69e-06	0.000119	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—RORA—stomach cancer	5.68e-06	0.000119	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NOS3—stomach cancer	5.67e-06	0.000119	CbGpPWpGaD
Naproxen—PTGS2—Disease—FYN—stomach cancer	5.65e-06	0.000118	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK8—stomach cancer	5.63e-06	0.000118	CbGpPWpGaD
Naproxen—PTGS2—Disease—ERCC2—stomach cancer	5.43e-06	0.000114	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—stomach cancer	5.39e-06	0.000113	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPP2R1A—stomach cancer	5.37e-06	0.000112	CbGpPWpGaD
Naproxen—AKR1C3—Disease—HRAS—stomach cancer	5.37e-06	0.000112	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—stomach cancer	5.36e-06	0.000112	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALDOB—stomach cancer	5.32e-06	0.000111	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGFR2—stomach cancer	5.31e-06	0.000111	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTP1—stomach cancer	5.27e-06	0.00011	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—stomach cancer	5.2e-06	0.000109	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HMOX1—stomach cancer	5.2e-06	0.000109	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—stomach cancer	5.19e-06	0.000108	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—stomach cancer	5.17e-06	0.000108	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.16e-06	0.000108	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—STAT3—stomach cancer	5.15e-06	0.000108	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD44—stomach cancer	5.14e-06	0.000107	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—stomach cancer	5.14e-06	0.000107	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD44—stomach cancer	5.11e-06	0.000107	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—stomach cancer	5.11e-06	0.000107	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTT1—stomach cancer	5.03e-06	0.000105	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.01e-06	0.000105	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5e-06	0.000105	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.99e-06	0.000104	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2A6—stomach cancer	4.97e-06	0.000104	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CAV1—stomach cancer	4.97e-06	0.000104	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOA1—stomach cancer	4.96e-06	0.000104	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.96e-06	0.000104	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALOX5—stomach cancer	4.94e-06	0.000103	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—stomach cancer	4.94e-06	0.000103	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK3—stomach cancer	4.92e-06	0.000103	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TYMS—stomach cancer	4.9e-06	0.000102	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DPYD—stomach cancer	4.86e-06	0.000102	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS2—stomach cancer	4.86e-06	0.000102	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PIK3CA—stomach cancer	4.86e-06	0.000102	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—stomach cancer	4.84e-06	0.000101	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKR1C3—stomach cancer	4.84e-06	0.000101	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—stomach cancer	4.82e-06	0.000101	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MYC—stomach cancer	4.79e-06	0.0001	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.75e-06	9.93e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ENO1—stomach cancer	4.72e-06	9.86e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CAV1—stomach cancer	4.71e-06	9.85e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOA1—stomach cancer	4.7e-06	9.83e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK1—stomach cancer	4.68e-06	9.79e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EGFR—stomach cancer	4.68e-06	9.78e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.64e-06	9.69e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—stomach cancer	4.61e-06	9.64e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ERCC2—stomach cancer	4.55e-06	9.51e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—stomach cancer	4.52e-06	9.45e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6ST—stomach cancer	4.47e-06	9.34e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—KRAS—stomach cancer	4.42e-06	9.24e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.41e-06	9.21e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—stomach cancer	4.37e-06	9.13e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPP2R1A—stomach cancer	4.37e-06	9.13e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPP2R1A—stomach cancer	4.34e-06	9.08e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTT1—stomach cancer	4.3e-06	8.99e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APC—stomach cancer	4.29e-06	8.97e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—stomach cancer	4.29e-06	8.97e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTP1—stomach cancer	4.29e-06	8.96e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—stomach cancer	4.28e-06	8.94e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTP1—stomach cancer	4.26e-06	8.91e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.25e-06	8.89e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMOX1—stomach cancer	4.23e-06	8.84e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—stomach cancer	4.22e-06	8.81e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMOX1—stomach cancer	4.2e-06	8.78e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD44—stomach cancer	4.18e-06	8.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.14e-06	8.64e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PIK3CA—stomach cancer	4.06e-06	8.49e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.06e-06	8.48e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MAPK3—stomach cancer	4.06e-06	8.48e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ENO1—stomach cancer	4.03e-06	8.42e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6R—stomach cancer	3.99e-06	8.33e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TYMS—stomach cancer	3.98e-06	8.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.96e-06	8.28e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—TYMS—stomach cancer	3.96e-06	8.28e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAV1—stomach cancer	3.95e-06	8.25e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—stomach cancer	3.94e-06	8.23e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOA1—stomach cancer	3.94e-06	8.23e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TP53—stomach cancer	3.93e-06	8.22e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—stomach cancer	3.93e-06	8.21e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—stomach cancer	3.92e-06	8.19e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MAPK1—stomach cancer	3.86e-06	8.07e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.77e-06	7.88e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HRAS—stomach cancer	3.76e-06	7.86e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—stomach cancer	3.76e-06	7.86e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—stomach cancer	3.73e-06	7.8e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ERCC2—stomach cancer	3.7e-06	7.74e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—ERCC2—stomach cancer	3.68e-06	7.7e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—KRAS—stomach cancer	3.65e-06	7.62e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—RHOA—stomach cancer	3.6e-06	7.52e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—stomach cancer	3.6e-06	7.52e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD44—stomach cancer	3.57e-06	7.47e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—stomach cancer	3.56e-06	7.45e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPP2R1A—stomach cancer	3.56e-06	7.43e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTP1—stomach cancer	3.49e-06	7.29e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—stomach cancer	3.48e-06	7.28e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—stomach cancer	3.47e-06	7.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.47e-06	7.25e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—stomach cancer	3.46e-06	7.23e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMOX1—stomach cancer	3.44e-06	7.19e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—stomach cancer	3.44e-06	7.19e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PIK3CA—stomach cancer	3.35e-06	7e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—ERBB2—stomach cancer	3.33e-06	6.97e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TYMS—stomach cancer	3.24e-06	6.78e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TP53—stomach cancer	3.24e-06	6.77e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAV1—stomach cancer	3.21e-06	6.71e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—stomach cancer	3.21e-06	6.7e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOA1—stomach cancer	3.2e-06	6.7e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PIK3CA—stomach cancer	3.19e-06	6.67e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAV1—stomach cancer	3.19e-06	6.67e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOA1—stomach cancer	3.19e-06	6.66e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—stomach cancer	3.12e-06	6.52e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HRAS—stomach cancer	3.1e-06	6.48e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1B—stomach cancer	3.09e-06	6.45e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.07e-06	6.41e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.05e-06	6.38e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.04e-06	6.35e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ERCC2—stomach cancer	3.01e-06	6.3e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—stomach cancer	2.98e-06	6.24e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTP1—stomach cancer	2.98e-06	6.23e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMOX1—stomach cancer	2.94e-06	6.14e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1A—stomach cancer	2.85e-06	5.95e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—stomach cancer	2.83e-06	5.92e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—stomach cancer	2.82e-06	5.9e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—stomach cancer	2.81e-06	5.87e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3CA—stomach cancer	2.78e-06	5.81e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TYMS—stomach cancer	2.77e-06	5.79e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—stomach cancer	2.74e-06	5.73e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAV1—stomach cancer	2.61e-06	5.46e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOA1—stomach cancer	2.61e-06	5.45e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3CA—stomach cancer	2.59e-06	5.42e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ERCC2—stomach cancer	2.58e-06	5.38e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—STAT3—stomach cancer	2.54e-06	5.31e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—stomach cancer	2.54e-06	5.31e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.5e-06	5.22e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MAPK3—stomach cancer	2.43e-06	5.08e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—stomach cancer	2.43e-06	5.07e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—stomach cancer	2.42e-06	5.06e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—stomach cancer	2.41e-06	5.05e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MYC—stomach cancer	2.36e-06	4.94e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MAPK1—stomach cancer	2.31e-06	4.83e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—EGFR—stomach cancer	2.31e-06	4.83e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—stomach cancer	2.3e-06	4.8e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAV1—stomach cancer	2.23e-06	4.67e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA1—stomach cancer	2.23e-06	4.66e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—stomach cancer	2.22e-06	4.64e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—stomach cancer	2.21e-06	4.61e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—KRAS—stomach cancer	2.18e-06	4.56e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.13e-06	4.46e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CA—stomach cancer	2.12e-06	4.42e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—stomach cancer	2.07e-06	4.32e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3CA—stomach cancer	2e-06	4.19e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—stomach cancer	1.98e-06	4.13e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—stomach cancer	1.96e-06	4.1e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—HRAS—stomach cancer	1.85e-06	3.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—stomach cancer	1.81e-06	3.78e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—stomach cancer	1.78e-06	3.71e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—stomach cancer	1.77e-06	3.69e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—stomach cancer	1.69e-06	3.53e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CA—stomach cancer	1.68e-06	3.51e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—stomach cancer	1.54e-06	3.23e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.37e-06	2.86e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CA—stomach cancer	1.36e-06	2.84e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.11e-06	2.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CA—stomach cancer	9.5e-07	1.99e-05	CbGpPWpGaD
